tracken
Maravai LifeSciences Aktie News
Neutral
Business Wire
●
13 Tage alt
SAN DIEGO--(BUSINESS WIRE)--TriLink BioTechnologies (TriLink®), a Maravai™ LifeSciences company (NASDAQ: MRVI) and global provider of life science reagents and services, is collaborating with the Johns Hopkins University to accelerate transformational research in RNA therapeutics and discovery. A new center within the Johns Hopkins Whiting School of Engineering will accelerate research and ther...
Neutral
GlobeNewsWire
●
17 Tage alt
SAN DIEGO, May 09, 2024 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to participate in the following investor conference during the months of May and June.
Neutral
Seeking Alpha
●
18 Tage alt
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI ) Q1 2024 Earnings Conference Call May 8, 2024 5:00 PM ET Company Participants Debbie Hart - Head, Investor Relations Trey Martin - Chief Executive Officer Kevin Herde - Chief Financial Officer Drew Burch - President, Nucleic Acid Production Becky Buzzeo - Chief Commercial Officer Conference Call Participants Matt Hewitt - Craig-Hallum Tejas Sava...
Neutral
GlobeNewsWire
●
18 Tage alt
Continued Focus on Product Portfolio Expansion, Market Leadership and Scientific Innovation Continued Focus on Product Portfolio Expansion, Market Leadership and Scientific Innovation
Neutral
Business Wire
●
26 Tage alt
SAN DIEGO--(BUSINESS WIRE)--TriLink BioTechnologies® and Lonza Enter into Non-exclusive License and Supply Agreement for CleanCap® mRNA Capping Technology.
Neutral
Business Wire
●
etwa ein Monat alt
SAN DIEGO--(BUSINESS WIRE)--TriLink BioTechnologies® Announces New San Diego Facility for Late Phase mRNA Drug Substance Production.
Neutral
GlobeNewsWire
●
etwa 2 Monate alt
SAN DIEGO, April 10, 2024 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its first quarter 2024 financial and operating results after the market closes on Wednesday, May 8, 2024, and will host a conference call and webcast on the same day at 2:00 p.m. PT/ 5:...
Neutral
GlobeNewsWire
●
2 Monate alt
SAN DIEGO, March 12, 2024 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to participate in the following investor conference during the month of March.
Kostenlos registrieren
aktien.guide ist das Tool zum einfachen Finden, Analysieren und Beobachten von Aktien. Lerne von erfolgreichen Investoren und triff fundierte Anlageentscheidungen. Wir machen Dich zum selbstbestimmten Investor.
